IDX panel highlights the continued problems around the new European trade reporting regime
A vast array of issues still surround the trade reporting
process with further complications on the horizon through
forthcoming mandates, according to a panel.
February 12 marked the beginning of trade reporting
requirements for OTC and exchange traded derivatives and the
industry is still yet to have an overall understanding of the
"We are four months in and a number of issues are the same
as four months ago," said David Broadway, senior technical
advisor, Investment Management Association, speaking at the IDX
Since the first European reporting requirements came into
force, issues around legal entity identifiers for
counterparties and unique trade identifiers have plagued the
This article is available exclusively to subscribers
Please log in to continue reading.
Not yet a subscriber?
Click here to take a free trial.
Already have an account? |
Please fill in your details below and a customer service representative will contact you.